What started out as a whim by a couple of software engineers led to a big breakthrough for MIM Software.In early 2008, MIM’s developers began hammering out the initial lines of code to what three years later became the first-ever medical imaging mobile app to be cleared for sale by the U.S. Food and Drug [...]
[Read more of this report]It’s hard to talk about the impact of Cleveland on the healthcare industry and vice versa without mentioning the institution that employs more than 39,000 northeast Ohioans and is consistently ranked as one of the country’s Top 5 hospitals. Its technology commercialization arm, which focuses solely on fostering innovation, is MedCity Media’s pick for The [...]
[Read more of this report]Pharmaceutical testing company ChanTest has achieved several “firsts” in its 13 years, most related to the company’s drug discovery work with electricity-producing proteins called ion channels.Add another: The Cleveland-area company has been chosen as the first recipient of MedCity Media’s”The Cities” Healthcare Ally award, given to a service provider that has demonstrated extraordinary service to [...]
[Read more of this report]Last year it all came crumbling down around the healthcare architecture firm Perspectus. One point away from victory in the 2010 MedCityNews.com Medical Cornhole Tournament, they lost to eventual champions Medical Mutual.But there are no Buffalo Bills in healthcare cornhole. Perspectus returned to the finals again and this time won the 2011 version of the [...]
[Read more of this report]Mark Twain’s quip that “news of my death was an exaggeration” sums up my reaction to the article on MetroHealth: “Healthcare reform’s impact: Farewell to public hospitals like MetroHealth.” The speculation that it’s all over for MetroHealth is wrong for three reasons.First, MetroHealth’s Board and management team have demonstrated an ability to manage the [...]
[Read more of this report]In the stockapocalypse that was Manic Monday, medical technology and pharma stocks got a mere slap on the wrist compared with banking stocks that received a more humiliating pants-down whipping.It appears that pharma stocks fared better than medical device and biotech stocks. GlaxoSmithKline (NYSE:GSK) was down a mere 28 cents to close at $39.44 on [...]
[Read more of this report]The future of public hospitals throughout the United States is imperiled, and for a preview on the impact of U.S. healthcare reform on hospitals, look no further than Cleveland’s public safety-net hospital, MetroHealth System.Faced with a raft of financial pressures and unfavorable trends, MetroHealth will likely have no choice but to essentially be swallowed up [...]
[Read more of this report]Word has it that Cleveland Clinic is gathering nominees from its staff for the best healthcare innovations of 2012: the Top 10 list that’s the cornerstone of the health system’s annual innovations summit.This year’s summit, which starts Oct. 3, will focus on cardiovascular technologies. But the list never focuses on one single technology. And since [...]
[Read more of this report]TheraVasc plans to begin enrolling patients this month in a phase 2a clinical trial of its pill designed to treat peripheral artery disease.The clinical trial, which is expected to follow 50 diabetic PAD patients for 11 weeks, could lead to big things for Cleveland-based TheraVasc. CEO Tony Giordano hopes a successful trial will position the [...]
[Read more of this report]Cleveland State University has hired a former Cleveland Clinic and University of Maryland cardiovascular researcher as the new dean of its College of Sciences and Health Professions.Meredith Bond, who most recently chaired the department of physiology at the University of Maryland’s School of Medicine, is scheduled to begin her tenure at CSU on July 18, [...]
[Read more of this report]